Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Family Medicine
Disease Category: Heart Disease
Location: United States, UT
This study is evaluating an FDA approved medication to prevent future heart attacks, stroke and possibly diabetes. The medication is designed to reduce systemic inflammation in the body.
This study is evaluating a medication for the prevention of future heart attacks, Strokes, and possibly Type 2 Diabetes.
The theory is, by reducing systemic inflammation, future heart attacks, strokes and possibly diabetes can be prevented. As a part of the study subject will have C-reactive protein tests performed. This new inflammation test may be an indicator of impending cardiovascular events.
Receive $50.00 per visit.
All labs, ECGs and study related care are provided at no cost.
Insurance is not needed to participate.
You will keep you current doctors and cardiologists.
You will NOT stop any of your current heart medications.
No cost to participate
Completely voluntary, you can withdraw at any time for any reason.
Patient Inclusion Criteria:
- Be over 18 years of age.
- Have had a previous heart attack.
Patient Exclusion Criteria:
- Must not have a history of cancer.
Jared Shields, Clinical Recruitment Coordinator
Optimum Clinical Research, Inc.
24 South 1100 East #205
Salt Lake City, UT 84102
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these